Form 4: Lemaitre Vascular Director John A. Roush Sells 7,500 Shares

Sentiment:

SEC Form 4


Director John A. Roush of Lemaitre Vascular Inc. (LMAT) sold 7,500 shares of common stock at $69 per share on March 7, 2024.

Summary

  • On March 7, 2024, John A. Roush, a director of Lemaitre Vascular Inc. (LMAT), sold 7,500 shares of the company's common stock.
  • The sale price was $69 per share.
  • Following the transaction, Roush directly owns 2,278 shares of common stock.
  • Roush also indirectly owns 181 shares through his wife.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of a stock sale by a company director. It doesn't inherently indicate positive or negative sentiment, but rather a factual transaction.

Industry Context

This Form 4 filing is a routine disclosure of insider trading activity. It provides transparency into the transactions of company insiders, allowing investors to monitor potential shifts in sentiment or alignment with company performance. However, without additional context, it's difficult to determine the specific reasons behind the sale.

Stakeholder Impact

  • The sale of shares by a director could potentially influence investor sentiment, although the impact is likely to be minimal given the relatively small number of shares involved.

Key Dates

DateDescription
03/07/2024Date of transaction: John A. Roush sold 7,500 shares of LMAT.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.